Ostia Lucille Smith (1885-1951) is the Great Great Aunt of Nick Deeter, Chairman of the Board & CEO of WishBone Medical, Inc. Along with Bertha Zimmer, Ostia Smith was one of the first two female sales representatives in orthopaedics for Revra DePuy. Ironically, Ostia’s first sale was a pediatric bone splint for the ankle to Dr. Leffers in Florida. Over one hundred years later, WishBone Medical is providing advanced technological solutions in the pediatric market.
In 2006, Nick Deeter started his first pediatric orthopedics company as he felt the standards for treatment in children were unacceptable. At best, adult orthopedic devices were altered and made smaller, without regard for the major physiological elements that differentiate kids’ anatomies from that of adults. Working alongside surgeons and engineers, Nick’s team worked to establish and build the niche industry of pediatric orthopedics.
In less than a decade, the pediatric orthopedics space evolved, awareness grew, and children were finally starting to get appropriate treatment.
Still, Deeter knew there were bigger frontiers to settle — that there are entirely NEW and MORE EFFECTIVE approaches to aid the startling amount of children who still receive implants unfit for their needs.
WishBone Medical burst onto the scene with a tenacious will to push industry standards and help children around the world. How? By equipping surgeons with innovative, anatomically appropriate implants and instruments in single-use, sterile packed procedure kits.
With smart selection and fortunate timing, the company made four major acquisitions, dramatically accelerating product launch activities.
And we’re only getting started.
WishBone Medical knows its customer and listens to their needs, which is crucial to creating product solutions that effectively solve the problem. Our customer, the pediatric orthopedic surgeon, is the best-trained and most experienced doctor to properly diagnose, treat and manage children’s musculoskeletal problems in a child who is still growing. This includes newborn babies through young adults (ages 0-21).
To this day, 95% of children continue to receive inappropriate, adult orthopedic products that were not originally intended for them, nor cleared by the FDA for use in children.* At best, the generic device is altered and made smaller, without regard for the fundamental physiological elements that differentiate pediatric anatomy from that of an adult.
Pediatric orthopedic implants MUST consider and be designed around children’s rapidly growing and morphing bodies. Our focus is on developing a broad portfolio to address the variety of conditions surgeons treat on a daily basis, with children’s unique needs in mind. It is our firm belief that children should prioritized above all else — medical care being no exception.
*Data on file.
Today, our ultimate goal is to make innovative pediatric orthopedic products accessible to surgeons to help children all over the world.
Learn how you can join these efforts by visiting the WishBone Orthopaedic Foundation online at www.wbof.org.